Prospective study of nonmyeloablative, HLA-mismatched unrelated BMT with high-dose posttransplantation cyclophosphamide

Allogeneic blood or marrow transplantation (BMT) candidates may lack HLA-matched, related haploidentical, and unrelated umbilical cord options. Barriers to partially HLA-mismatched, unrelated donor (mMUD) BMT include excess graft-versus-host disease (GVHD), graft failure, and death. We prospectively...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Blood Adv
Asıl Yazarlar: Kasamon, Yvette L., Ambinder, Richard F., Fuchs, Ephraim J., Zahurak, Marianna, Rosner, Gary L., Bolaños-Meade, Javier, Levis, Mark J., Gladstone, Douglas E., Huff, Carol Ann, Swinnen, Lode J., Matsui, William H., Borrello, Ivan, Brodsky, Robert A., Jones, Richard J., Luznik, Leo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Hematology 2017
Konular:
Transplantation
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5726600/
https://ncbi.nlm.nih.gov/pubmed/29242852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2016002766
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller